Electronic cigarettes and cardiovascular disease: epidemiological and biological links.
Level 5 - mechanism / opinion, no new human data
Narrative minireview synthesizing mechanisms and epidemiology without systematic review methodology
PubMed 38376568 · doi:10.1007/s00424-024-02925-0
What was done
This narrative minireview synthesized published epidemiological and mechanistic literature evaluating the cardiovascular effects of electronic cigarette emissions, including nicotine, propylene glycol, flavorings, nitrosamines, and metals.
What was found
The abstract provides no quantitative data or numerical effect estimates. It qualitatively reports that e-cigarette use is associated with modest increases in the incidence and mortality of cardiovascular diseases, including cardiac arrhythmia, hypertension, acute coronary syndromes, and heart failure. It identifies oxidative stress, inflammation, endothelial dysfunction, atherosclerosis, hemodynamic alterations, and platelet dysfunction as validated biological mechanisms.
Why it matters
It consolidates mechanistic pathways and epidemiological associations to summarize cardiovascular health risks associated with e-cigarette use.
Limits
As an unsystematic narrative review, it reports no quantitative effect sizes, confidence intervals, or sample sizes in the abstract. Key epidemiological confounders such as prior or concurrent combustible tobacco smoking are not detailed.
Cited by
- supports A 2024 study found that e-cigarette users were 20% more likely to develop heart failure.